来自北欧和南欧国家的α-1抗胰蛋白酶缺乏症患者的特征：EARCO国际登记处 - Suppr | 超能文献

Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry.

作者信息

Miravitlles Marc, Turner Alice M, Torres-Duran María, Tanash Hanan, Rodríguez-García Carlota, López-Campos José Luis, Chlumsky Jan, Guimaraes Catarina, Rodríguez-Hermosa Juan Luis, Corsico Angelo, Martinez-González Cristina, Hernández-Pérez José María, Bustamante Ana, Parr David G, Casas-Maldonado Francisco, Hecimovic Ana, Janssens Wim, Lara Beatriz, Barrecheguren Miriam, González Cruz, Stolk Jan, Esquinas Cristina, Clarenbach Christian F

机构信息

Pneumology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

出版信息

Eur Respir J. 2023 Mar 30;61(3). doi: 10.1183/13993003.01949-2022. Print 2023 Mar.

DOI:10.1183/13993003.01949-2022

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry.来自北欧和南欧国家的α-1抗胰蛋白酶缺乏症患者的特征：EARCO国际登记处

Eur Respir J. 2023 Mar 30;61(3). doi: 10.1183/13993003.01949-2022. Print 2023 Mar.

2

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.α-1 抗胰蛋白酶缺乏个体的临床和功能特征：EARCO 国际登记处。

Respir Res. 2022 Dec 16;23(1):352. doi: 10.1186/s12931-022-02275-4.

3

Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency.意大利α1-抗胰蛋白酶缺乏症登记处携带罕见变异的受试者的患病率和表型

J Med Genet. 2005 Mar;42(3):282-7. doi: 10.1136/jmg.2004.023903.

4

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.α-1 抗胰蛋白酶缺乏症患者支气管扩张症的患病率：EARCO 的初步报告。

Orphanet J Rare Dis. 2023 Aug 12;18(1):243. doi: 10.1186/s13023-023-02830-2.

5

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency.欧洲α-1研究协作组（EARCO）：欧洲呼吸学会促进α-1抗胰蛋白酶缺乏症研究的一项新临床研究协作项目。

Eur Respir J. 2019 Feb 14;53(2). doi: 10.1183/13993003.00138-2019. Print 2019 Feb.

6

Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症。1：α1-抗胰蛋白酶缺乏症的流行病学

Thorax. 2004 Feb;59(2):164-9. doi: 10.1136/thorax.2003.006494.

7

Alpha1-antitrypsin deficiency and Pi typing.α1-抗胰蛋白酶缺乏症与Pi分型

J Allergy Clin Immunol. 2008 Sep;122(3):658. doi: 10.1016/j.jaci.2008.06.019. Epub 2008 Jul 30.

8

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.新型以患者为中心的 α-1 抗胰蛋白酶缺乏症管理方法。

Int J Chron Obstruct Pulmon Dis. 2020 Feb 12;15:345-355. doi: 10.2147/COPD.S234646. eCollection 2020.

9

[Alpha1-antitrypsin deficiency in Austria: analysis of the Austrian Alpha1-international-registry database].[奥地利的α1抗胰蛋白酶缺乏症：奥地利α1国际注册数据库分析]

Wien Klin Wochenschr. 2010 Jul;122(13-14):390-6. doi: 10.1007/s00508-010-1399-9. Epub 2010 Jul 14.

10

[The role of alpha-1-antitrypsin phenotypes in the pathogenesis or rheumatic diseases].

Pol Arch Med Wewn. 2001 May;105(5):409-15.

引用本文的文献

1

Clinical characteristics of AATD-related COPD patients vary with age at diagnosis: data from the EARCO international registry.α1抗胰蛋白酶缺乏症（AATD）相关慢性阻塞性肺疾病（COPD）患者的临床特征随诊断年龄而异：来自EARCO国际注册研究的数据

BMC Pulm Med. 2025 Jul 4;25(1):321. doi: 10.1186/s12890-025-03782-y.

2

Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges.α-1抗胰蛋白酶缺乏症与支气管哮喘：当前挑战

Biomolecules. 2025 Jun 3;15(6):807. doi: 10.3390/biom15060807.

3

Characterization of the Mmalton carrier's cohort within the EARCO (European Alpha- 1 Antitrypsin Research Collaboration) registry.欧洲α-1抗胰蛋白酶研究协作组（EARCO）登记处中Mmalton携带者队列的特征分析。

BMC Pulm Med. 2025 Apr 23;25(1):187. doi: 10.1186/s12890-025-03651-8.

4

Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.PI*SS 基因型的α-1 抗胰蛋白酶缺乏症与肺部疾病风险：EARCO 研究项目。

Respir Res. 2024 Jun 26;25(1):260. doi: 10.1186/s12931-024-02879-y.